// App-Quantinova.ai

Mo1660 : EFFECT OF ADALIMUMAB ON EXTRAINTESTINAL MANIFESTATIONS AMONG PATIENTS WITH ULCERATIVE.COLITIS IN A CLINICAL PRACTICE SETTING: RESULTS FROM INSPIRADA

Researchers

Presenter

  • Brian G. Feagan

Principal Investigators

  • Laurent Peyrin-Biroulet

  • Naijun Chen

  • Martha Skup

  • Remo Panaccione

  • Silvio Danese

  • Andreas Lazar

  • Anne M. Robinson

  • Roopal B. Thakkar

  • Brandee Pappalardo

  • Joel H. Petersson

  • Mareike Bereswill

Medical Centers

  • Istituto Clinico Humanitas, Milan, Italy

  • University Hospital of Lille, Lille, France

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • University of Calgary, Calgary, AB, Canada

  • Robarts Reserach Institute, London, ON, Canada

Locations

  • France

  • Canada

  • United Kingdom

  • Italy

Companies

  • AbbVie Inc.

Study Components

Therapeutic Area

  • Ophthalmology (OP)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

Outcome

  • Unknown

Study Design

  • open label

  • single arm

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved